Objectives: Delays in the diagnosis and detection of bipolar disorder can lead to adverse consequences, including improper treatment and increased suicide risk. The Mood Spectrum Self-Report Measure (MOODS-SR) was designed to capture the full spectrum of lifetime mood symptomology with factor scores for depression and mania symptom constellations. The utility of the MOODS-SR as a tool to investigate homogeneous subgroups was examined, with particular focus on a possible bipolar risk subgroup. Moreover, potential patterns of differences in MOODS-SR subtypes were probed using cognitive vulnerabilities, neuropsychological functioning, and ventral striatum connectivity.
| INTRODUC TI ON
Major depressive disorder (MDD) is diagnosed as a separate illness from bipolar disorder (BD), yet the behavioral, clinical, performance, genetic, and neuroimaging differences between these groups have been limited to modest. Indeed, both MDD and BD share major depressive episodes, one reason why it is not surprising that there are overlapping traits in the literature. [1] [2] [3] [4] Furthermore, any measurement that yields a single score for MDD likely misrepresents the heterogeneity of the disorder, 5 and does not necessarily rule out bipolar spectrum symptoms. Furthermore, early in the course of the illness, a substantial minority of those presenting with MDD will later be diagnosed with BD. 6, 7 It is well understood that BD is often missed in screening batteries for those presenting with mood spectrum pathology and initial evaluations for major depressive disorder. 8 For example, BD is often incorrectly diagnosed and not treated until 10-20 years after onset, usually about 14 years. 9 This underdiagnosis of hypomania and mania often leads to poorer prognosis due to delay in start of treatment, greater disruptions in the life course, adverse life events related to untreated manias, and increased risk for suicide. 8, 10 Difficulties in the diagnosis of BD can stem from many sources. Lack of subjective distress during hypomanic and manic episodes, and "normalization" of some risky behaviors associated with mania during young adulthood (eg, sleep deprivation, substance abuse, sexual experimentation) 11, 12 can contribute to under or delayed diagnosis. Therefore, mania is a substantial, poorly perceived risk in the late adolescent and young adult period for those with a history of MDD. Faster and more accurate diagnosis is a current area of need for this age period.
A number of different methods have been employed to increase specificity in assessment tools for MDD and BD (eg, defining more homogeneous groups by psychomotor disturbance levels or anxiety). 13, 14 These methods have demonstrated some success-for example, depressed individuals with lower reward responsiveness and higher anhedonia are more likely to have difficulty pursuing simple rewards 7 and those with melancholic subtype depression tend to have more psychomotor slowing and set-shifting difficulty. 15 More recently, large studies using RDoC approaches with dimensional strategies have been able to define subcategories: of mood disorders; one through use of Go/NoGo responding and another using event-related potentials. 16, 17 A combined dimensional and lifespan approach to mood disorders may aid in more accurate diagnoses by collecting more detailed information about prior episodes and periods of relative wellness. For example, spectrum models take into account that depression symptoms can be elevated repeatedly at various points over the lifespan or even that certain symptoms never occur at all, an idea not accounted for in binary categories of current or recent diagnosis. 18 Moreover, some symptom patterns may not always be present at the point of assessment, yet may be pathognomonic.
For example, severe anhedonia may only be present in one of many prior episodes and would not be specified within a current or most recent past diagnosis. Assessing the full spectrum of symptoms across the lifespan may aid in early detection and diagnosis.
One way to measure the full spectrum of symptoms involved in mood disorders is to assess factors of depressive and manic symptoms over the lifetime, including prodromal and subthreshold behavioral manifestations, such as through the Mood Spectrum Indeed, disruption in the functional circuits in the brain, particularly those supporting emotion processing, emotion regulation, and reward processing, have been observed in those with BD. 24 One particular region of interest in these functional circuits, and particularly within resting-state functional connectivity analyses, has been the ventral striatum, involved in reward processing, anhedonia, and behavioral activation. The VS regions, and these related constructs, are all potential sources of difference between MDD and BD. In particular, this region has shown differences in function and structure in those with BD and those at risk for the development of BD. 6 A recent review has noted increased volume, decreased gray matter in those at risk, and increased activity at rest in the ventral striatum. 7 Disrupted connectivity between the VS and other regions of the brain may represent an early neural marker of BD. 6 Abnormalities and disruptions to this region may correspond to the onset and risk for developing BD.
In the present study, the goal is to identify subtypes of MDD, particularly subtypes that are at-risk for developing BD. We hypothesize that different subgroups based on mood symptoms of this young adult sample can be defined using cluster-analysis. We also expect that these subgroups would display different cognitive vulnerabilities, neuropsychological functioning, and neural connectivity related to the ventral striatum, particularly as it hones in on lifetime hypo/mania vulnerability. Interview for Genetic Studies. 26 All data reported were collected over separate intake, cognitive testing, and fMRI sessions.
| ME THODS

| Mood Spectrum Self-Report (MOODS-SR)
The MOODS-SR has 161 yes or no questions regarding whether the participant has experienced various situations now or in the past, which are then summed into factors. 
| Clinical variables
Clinical variables of interest regarding illness were collected through the DIGS, including age of first episode, number of depressive episodes, length of longest depressive episode, and Global Assessment of Functioning (GAF). 25 Family history was ascertained as part of the DIGS, adapted FIGS, and Longitudinal Interval Follow-up Evaluations (LIFE), coded for the presence of any mood disorder.
| Questionnaire Measures
The Ruminative Responses Scale (RRS) is a self-report measure of rumination. 27 Two motivational systems were measured by the BIS/ BAS. 28 The Barratt Impulsiveness Scale (BIS-11) is a self-report measure of impulsive behavior and preferences. 29 The NEO-Personality
Inventory-Revised (NEO-PI-R) was administered to assess five major domains of personality: Openness to Experience, Conscientiousness, Extraversion, Agreeableness, and Neuroticism. 30 
| Neuropsychological measures
Estimated Intelligence Quotient was assessed using the Synonym Knowledge Task to determine if subtypes differ in global cognitive ability. 31 The Facial Emotion Perception Test (FEPT) is a test of accuracy and speed in identification of facial expressions including accuracy for fear, anger, happy, sad, and neutral faces. 32 The Modified, Titrated Monetary Incentive Delay Task (mMID) is a simple, contingent reward sensitivity task dependent on responding to a rapid response window. The task is titrated based on the participant's accuracy and speed to optimize performance to perceived difficulty ratios. 33 Money earned during the last two runs was used as the dependent variable. The Parametric Go/No-Go Task captures sustained attention, inhibitory control, and processing speed to target cues. 32, 34 Reaction time and percent correct inhibition were assessed for both 2 and 3 target trials. Controlled
Oral Word Association Test (COWA) provides a measure of verbal fluency to confrontation based on cues of the first consonant in words. 35 The Wisconsin Card Sorting Test provides a measure of executive functioning, including inferential problem solving using error percentiles. 36 Trail Making A/B and C/D were also administered, capturing visual speed and switching, respectively. 37 The
Purdue Pegboard provides a measure of bimanual dexterity.
| fMRI acquisition
The 
| fMRI preprocessing
We took several steps to reduce effects of noise and artifact. Slice time correction was completed in SPM8 (https://www.fil.ion.ucl.
ac.uk/spm/doc/), and we applied motion detection and correction algorithms using FSL (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). We used coregistration of structural images to functional images. Next, we used spatial normalization of the coregistered T1-spgr to the Montreal Neurological Institute (MNI) template. The normalization matrix was applied to the slice-time-corrected, time series data. The result, normalized T2* timeseries data, was spatially smoothed with a 5-mm Gaussian kernel producing T2* images with isotropic voxels, 2 mm on a side.
| fMRI cross-correlation analysis
Time series data were detrended and mean-centered. Additionally, physiologic correction was performed by regressing out white matter and cerebral spinal fluid signals. 38 Motion parameters were regressed out. 39 Global signal was not regressed due to collinearity violations with gray matter signal, challenging mis-estimates of anticorrelations, 40 and nonlinear impact on distance-micromovement relationships. 39 Time-series were band-pass filtered over 0.01-0.10 Hz. Seeds were derived based on previous literature examining resting state connectivity of the ventral striatum. 41 The Table 1 ).
| Cluster group comparisons
A series of ANOVAs were computed between the three cluster groups. For questionnaire measures, and neuropsychological tests, significant ANOVAS were followed by post hoc tests with Bonferroni corrections to determine specific differences between patient clusters. For rs-fMRI, a threshold of P < 0.005 and cluster extent of 57 voxels was used (P <0.01 corrected for each model) based on the updated 2016 version of 3dClustsim. 42 Data from significant areas of group differences in connectivity were extracted using Marsbar (https:// marsbar.sourceforge.net) and compared using post hoc t-tests (Bonferroni corrected).
| RE SULTS
| Cluster analysis
The Table 1 ). There was a main effect of group on all measures of the MOODS-SR (Table 1) . Post hoc tests were run to determine pairwise differences. The Min cluster was significantly lower than Sev on all factors (P < 0.001). Min was significantly lower than Mod on all factors (all P < 0.02) except Sociability/Extraversion, Spirituality/Mysticism/Psychoticism, and Wastefulness. Sev was higher than Mod on all factors except for Depressed Mood and Suicidality (Table 1) . Clinically, Min was higher in GAF than Mod and Sev (P < 0.001; P < 0.001; Table 1 ).
Those in Sev group were numerically, but not significantly more 
| Connectivity to RVSs
Results are reported in Supplemental 
| Connectivity to LVSs
Results are reported in Supplemental Table S2 and Figure 3 .
There is a main effect of group in a large number of networks, 
| Connectivity to RVSi
Results are reported in Supplemental Table S3 and Figure 4 .
There was a main effect of group for the precuneus and the vermis. Post hoc Bonferroni tests were run to determine pairwise differences. In the precuneus, Sev was significantly higher than Min and Mod. Connectivity with the vermis was significantly higher in Sev vs Min and Mod.
| Connectivity to LVSi
There were no significant main effect of group observed for LVSi.
| Questionnaire measures
There was a significant main effect of group on the RRS, BIS-11 Total, BAS Total, Neuroticism, Extraversion, Openness, and Consciousness ( 
| Neuropsychological variables
There was a significant main effect of group on fear and anger accuracy (Table 3) . Post hoc Bonferroni tests were run to determine pairwise differences. Sev performed significantly better on fear accuracy than Min and Mod, and better in anger accuracy than Min. All other neuropsychological tests did not show a statistically significant main effect of group.
| D ISCUSS I ON
The present study was conducted to ascertain whether lifetime symptoms of depression and mania might aid in detecting more homogeneous subgroups of MDD. This study yielded three different cluster groups based on lifetime symptoms within an otherwise homogeneous sample of remitted MDD young adults and age matched healthy comparison adults. We were able to detect a group with minimal mood symptomology (primarily HCs and at a lower risk of developing mood pathology), a group with moderate and primarily unipolar symptomology (Mod), and a group that was more severe in both elevated manic and depressive symptomology (Sev). We were able to illustrate differences that delineated the Mod and Sev clusters, including differences in connectivity with the VS, facial perception performance, self-reported impulsivity, and self-reported extraversion and conscientiousness. This appears to be the first study to examine the MOODS-SR in a remitted sample, and to highlight that a bipolar risk subgroup could potentially be defined with MOODS-SR early in the course of MDD.
There was a small group of individuals currently remitted for MDD who endorsed significantly higher lifetime mania symptoms, although not clinically elevated to the point that it would be captured in diagnostic interviews. This finding is consistent with the presence of many prodromal symptoms before the development and awareness of BD, including mood lability and elation, swings or cyclothymic features, racing thoughts, irritability, and psychomotor activation, (many of the mania factors in the MOODS-SR). 43, 44 This group also endorsed more severe lifetime depressive symptoms in four factors. Sev may represent a distinct MDD group with substhreshold manic symptomology, who 53 Depending on the length of the observation period, 15%-30% of people who were previously diagnosed as unipolar progress to BD. 54 Thus, not only could use of the MOODS-SR in this age range lead to designation of individuals in "high risk" categories, it may also lead to earlier treatment and improved prevention efforts. Indeed, there may be increased specificity in the nature and types of treatments that could work for these subgroups. Identification of neural, neuropsychological, or personality features that aid in risk determination could lead to earlier and more effective treatment.
This study has a few limitations to cover. A strength of the study was that multiple methods were used to validate subgroups; however, future studies will be needed to further validate links to BD by recruiting groups with elevated lifetime mania symptoms with and without a history of BD. Additionally, these studies would benefit from larger sample sizes to increase power, as the present study was a secondary data analysis with a sample of convenience. The sample size was not large enough to form additional cluster subgroups
(to evaluate what might be an optimal cluster number) because sufficient power would have been lost to determine trait differences between smaller cluster groups. The three-cluster solution was only marginally lower in AIC relative to the two-and four-cluster solutions and was identical in the silhouette measure. A larger sample size would be beneficial in determining further homogeneous subgroupings/clusters in those with mood disorders. In addition, some measures expected to vary across mood clusters did not show significant differences between our clusters, such as inhibition or bimanual dexterity. This may have been due to a focus on lifetime mood symptomology in a currently remitted sample, which is more likely to highlight trait rather than state differences. Finally, we were unable to prospectively follow this sample to determine final diagnostic outcomes, and thus empirically testing conversion from MDD diagnosis to BD remains an active area of research. Alternatively, comparison to a group with diagnosis of BD could have clarified whether the BD and Sev groups were similar on a number of neuropsychological, trait, and brain imaging features. Future studies will need to determine the course of illness in such groups, and to determine if these groups are a risk group for BD or if they represent a subtype of MDD with subthreshold mania symptomology.
In conclusion, the MOOD-SR is a useful tool to reduce homogeneity within young, remitted MDD samples. It also may be a useful tool to identify those at risk for developing BD, even in those whose illness clinically and historically presents as unipolar. There may be a subgroup of people with depression histories who have been improperly diagnosed or are at risk of developing more severe pathology in the future. It is more likely that there is an MDD subgroup with some subthreshold manic symptomatology, and these individuals may show a different clinical course with different optimal treatments.
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